The diagnosis and treatment of thyroid-associated ophthalmopathy
- PMID: 22083413
- DOI: 10.1007/s00266-011-9843-4
The diagnosis and treatment of thyroid-associated ophthalmopathy
Abstract
Background: Little is written in the plastic surgery literature about thyroid-associated ophthalmopathy (TAO), a condition that is separate from Graves-Basedow disease and may not be accompanied by hyperthyroidism. Many patients with this disease frequently seek periocular aesthetic reconstruction prior to medical workup.
Methods: This study presents a comprehensive review of the literature surrounding TAO in order to better understand the prevalence, diagnosis, pathophysiology, and appropriate management of TAO.
Results: TAO is frequently under- or misdiagnosed by health-care providers. Patients seeking blepharoplasty or other oculoplastic procedures may have underlying TAO, and the prevalence of TAO in patients who have had a blepharoplasty is approximately 3%. This condition occurs five times more often in women than in men. As a product of the relatively high prevalence of this disease and its underdiagnosis, TAO patients may experience perioperative and late complications due to surgery.
Conclusion: Blepharoplasties performed on TAO patients must be undertaken with care and insight to avoid cosmetic and functional complications.
Similar articles
-
Thyroid ophthalmopathy.Minerva Endocrinol. 2005 Dec;30(4):247-65. Minerva Endocrinol. 2005. PMID: 16319812 Review.
-
[Choice the appropriate therapy according to the clinical features of the thyroid associated ophthalmopathy].Zhonghua Yan Ke Za Zhi. 2006 Dec;42(12):1060-2. Zhonghua Yan Ke Za Zhi. 2006. PMID: 17415960 Chinese.
-
[Emphasizing the fundamental and clinical research on thyroid-associated ophthalmopathy].Zhonghua Yan Ke Za Zhi. 2005 Sep;41(9):769-71. Zhonghua Yan Ke Za Zhi. 2005. PMID: 16191339 Chinese.
-
Management of Graves' ophthalmopathy.Nat Clin Pract Endocrinol Metab. 2007 May;3(5):396-404. doi: 10.1038/ncpendmet0497. Nat Clin Pract Endocrinol Metab. 2007. PMID: 17452966 Review.
-
An update on thyroid-associated ophthalmopathy in children and adolescents.J Pediatr Endocrinol Metab. 2016 Oct 1;29(10):1115-1122. doi: 10.1515/jpem-2016-0122. J Pediatr Endocrinol Metab. 2016. PMID: 27682712 Review.
Cited by
-
Predicting the response to glucocorticoid therapy in thyroid-associated ophthalmopathy: mobilizing structural MRI-based quantitative measurements of orbital tissues.Endocrine. 2020 Nov;70(2):372-379. doi: 10.1007/s12020-020-02367-5. Epub 2020 Jun 5. Endocrine. 2020. PMID: 32504380
-
Disrupted Spontaneous Neural Activity in Patients With Thyroid-Associated Ophthalmopathy: A Resting-State fMRI Study Using Amplitude of Low-Frequency Fluctuation.Front Hum Neurosci. 2021 Jun 11;15:676967. doi: 10.3389/fnhum.2021.676967. eCollection 2021. Front Hum Neurosci. 2021. PMID: 34177495 Free PMC article.
-
Biomarker identification of thyroid associated ophthalmopathy using microarray data.Int J Ophthalmol. 2018 Sep 18;11(9):1482-1488. doi: 10.18240/ijo.2018.09.09. eCollection 2018. Int J Ophthalmol. 2018. PMID: 30225222 Free PMC article.
-
T2 Mapping with and without Fat-Suppression to Predict Treatment Response to Intravenous Glucocorticoid Therapy for Thyroid-Associated Ophthalmopathy.Korean J Radiol. 2022 Jun;23(6):664-673. doi: 10.3348/kjr.2021.0627. Epub 2022 Apr 26. Korean J Radiol. 2022. PMID: 35555881 Free PMC article.
-
Abnormal regional spontaneous neural activity and functional connectivity in thyroid-associated ophthalmopathy patients with different activity: a resting-state fMRI study.Front Neurol. 2023 Jul 5;14:1199251. doi: 10.3389/fneur.2023.1199251. eCollection 2023. Front Neurol. 2023. PMID: 37475733 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials